<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
____________
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 2)
ONCOGENE SCIENCE, INC.
----------------------
(Name of Issuer)
COMMON STOCK, $.01 PAR VALUE
----------------------------
(Title of Class of Securities)
682305 10 7
-----------
(CUSIP Number)
(continued on following pages (s))
Page 1 of 5 pages
<PAGE>
CUSIP NO. 682305 10 7 PAGE 2 OF 5 PAGES
----------- -----------------
- ------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
BECTON, DICKINSON AND COMPANY
- ------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A
MEMBER OF A GROUP
(A) [_]
(B) [_]
NOT APPLICABLE
- ------------------------------------------------------------------------------
3 SEC USE ONLY
- ------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
NEW JERSEY
- ------------------------------------------------------------------------------
5 SOLE VOTING POWER
NONE
------------------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES NONE
------------------------------------------------------------
BENEFICIALLY 7 SOLE DISPOSITIVE POWER
OWNED BY EACH NONE
------------------------------------------------------------
REPORTING PERSON
8 SHARED DISPOSITIVE POWER
WITH
NONE
- ------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
NONE
- ------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES
NOT APPLICABLE
- ------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0%
- ------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
CO
- ------------------------------------------------------------------------------
<PAGE>
CUSIP NO. 682305 10 7 PAGE 3 OF 5 PAGES
----------- -----------------
AMENDMENT NO. 2
---------------
STATEMENT ON SCHEDULE 13G PURSUANT TO RULE 13d-1(c)
OF THE GENERAL RULES AND REGULATIONS UNDER THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
ITEM 1(A) NAME OF ISSUER.
---------------
Oncogene Science, Inc.
ITEM 1(B) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES.
---------------------------------------------------------
106 Charles Lindbergh Boulevard, Uniondale, New York 11553
ITEM 2(A) NAMES OF PERSON FILING.
-----------------------
Becton, Dickinson and Company
ITEM 2(B) ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR IF NONE, RESIDENCE.
------------------------------------------------------------
One Becton Drive, Franklin Lakes, New Jersey 07417-1880
ITEM 2(C) CITIZENSHIP.
------------
New Jersey
ITEM 2(D) TITLE OF CLASS OF SECURITIES.
-----------------------------
Common Stock, $.01 par value
ITEM 2(E) CUSIP NUMBER.
-------------
682305 10 7
<PAGE>
CUSIP NO. 682305 10 7 PAGE 4 OF 5 PAGES
----------- -----------------
ITEM 3 THIS STATEMENT IS NOT FILED PURSUANT TO RULES 13D-1(B) OR 13D-2(B).
ITEM 4. OWNERSHIP.
On January 31, 1997, Becton, Dickinson and Company ("Becton") disposed
of all of the shares of Common Stock of Oncogene Science, Inc. which were
beneficially owned by Becton. As a result of said transaction, Becton no longer
beneficially owns any Common Stock of Oncogene Science, Inc.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
Not applicable
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
Not applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable
ITEM 10. CERTIFICATION.
Not applicable
<PAGE>
CUSIP NO. 682305 10 7 PAGE 5 OF 5 PAGES
----------- -----------------
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
BECTON, DICKINSON AND COMPANY
Dated: July 17, 1997 By: /s/ BRIDGET M. HEALY
---------------------
Bridget M. Healy
Vice President and Secretary
